PAPER Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, Parker SJ, Greenough MA, Volitakis I, Adlard PA, Cherny RA, Masters CL, Bush AI, Barnham KJ, White AR
SEARCH RESULTS
330026 RESULTS
PAPER Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Passmore P, Morgan K, , Younkin SG
Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study.
Mol Neurodegener. 2011;6(1):54. PubMed: 21798052PAPER Zhou F, Gong K, van Laar T, Gong Y, Zhang L
Wnt/β-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity.
Biochem Biophys Res Commun. 2011 Aug 19;412(1):68-73. PubMed: 21798242PAPER Bruce-Keller AJ, Gupta S, Knight AG, Beckett TL, McMullen JM, Davis PR, Murphy MP, Van Eldik LJ, St Clair D, Keller JN
Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.
Neurobiol Dis. 2011 Dec;44(3):317-26. PubMed: 21798347PAPER Liu Y, Hua Q, Lei H, Li P
Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
J Ethnopharmacol. 2011 Sep 2;137(2):1035-46. PubMed: 21798326PAPER Rizzo S, Bisi A, Bartolini M, Mancini F, Belluti F, Gobbi S, Andrisano V, Rampa A
Multi-target strategy to address Alzheimer's disease: design, synthesis and biological evaluation of new tacrine-based dimers.
Eur J Med Chem. 2011 Sep;46(9):4336-43. PubMed: 21798635PAPER Maruszak A, Safranow K, Branicki W, Gawęda-Walerych K, Pośpiech E, Gabryelewicz T, Canter JA, Barcikowska M, Zekanowski C
The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk.
J Alzheimers Dis. 2011 Jan 1;27(1):197-210. PubMed: 21799244PAPER Choi IS, Lee YJ, Choi DY, Lee YK, Lee YH, Kim KH, Kim YH, Jeon YH, Kim EH, Han SB, Jung JK, Yun YP, Oh KW, Hwang DY, Hong JT
4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):127-41. PubMed: 21799245PAPER Didic M, Barbeau EJ, Felician O, Tramoni E, Guedj E, Poncet M, Ceccaldi M
Which memory system is impaired first in Alzheimer's disease?
J Alzheimers Dis. 2011 Jan 1;27(1):11-22. PubMed: 21799246PAPER Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, Lötjönen J,
A disease state fingerprint for evaluation of Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):163-76. PubMed: 21799247PAPER Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY, Gouras GK, Lin MT, Beal MF
Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.
J Alzheimers Dis. 2011;27(1):211-23. PubMed: 21799249PAPER Li C, Wang J, Gui L, Zheng J, Liu C, Du H
Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease.
J Alzheimers Dis. 2011;27(2):281-90. PubMed: 21799248PAPER Yang K, Belrose J, Trepanier CH, Lei G, Jackson MF, Macdonald JF
Fyn, a potential target for Alzheimer's disease.
J Alzheimers Dis. 2011;27(2):243-52. PubMed: 21799250PAPER Gao B, Long Z, Zhao L, He G
Effect of normobaric hyperoxia on behavioral deficits and neuropathology in Alzheimer's disease mouse model.
J Alzheimers Dis. 2011;27(2):317-26. PubMed: 21799251PAPER Ma L, Ohyagi Y, Nakamura N, Iinuma KM, Miyoshi K, Himeno E, Soejima N, Yanagihara YT, Sakae N, Yamasaki R, Kira J
Activation of glutathione peroxidase and inhibition of p53-related apoptosis by apomorphine.
J Alzheimers Dis. 2011 Jan 1;27(1):225-37. PubMed: 21799252Current Filters
No filters selected